Published in J Eur Acad Dermatol Venereol on December 01, 2010
Psoriatic Pseudobalanitis Circinata as a Post-Viral Koebner Phenomenon. Case Rep Dermatol (2010) 0.86
New FIGO staging system of vulvar cancer indeed provides a better reflection of prognosis. Gynecol Oncol (2010) 2.27
Pretreatment to enhance protoporphyrin IX accumulation in photodynamic therapy. Dermatology (2008) 1.82
A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction. Br J Dermatol (2005) 1.72
Management of palmoplantar pustulosis: do we need to change? Br J Dermatol (2011) 1.49
Lymphocyte subsets in peripheral blood of patients with moderate-to-severe versus mild plaque psoriasis. Arch Dermatol Res (2007) 1.47
[Wait-and-see policy versus loop excision after two consecutive Pap-2 cervical smears: over time less surgery and an equivalent outcome; no substantial contribution to be expected from the detection of high risk human papillomavirus]. Ned Tijdschr Geneeskd (2003) 1.45
Surveillance of women at high risk for hereditary ovarian cancer is inefficient. Br J Cancer (2006) 1.45
Narrowband ultraviolet B therapy in psoriasis: randomized double-blind comparison of high-dose and low-dose irradiation regimens. Br J Dermatol (2009) 1.41
The Impact of Chronic Skin Disease on Daily Life (ISDL): a generic and dermatology-specific health instrument. Br J Dermatol (2007) 1.40
Disease recurrence in localized scleroderma: a retrospective analysis of 344 patients with paediatric- or adult-onset disease. Br J Dermatol (2015) 1.40
The effectiveness and safety of short-contact dithranol therapy in paediatric psoriasis: a prospective comparison of regular day care and day care with telemedicine. Br J Dermatol (2014) 1.39
Relevance of laboratory investigations in monitoring patients with psoriasis on etanercept or adalimumab. Br J Dermatol (2011) 1.39
Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways. Int J Gynecol Pathol (2006) 1.31
No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study. Br J Cancer (2007) 1.30
European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey. Br J Dermatol (2006) 1.30
Induction of eruptive benign melanocytic naevi by immune suppressive agents, including biologicals. Br J Dermatol (2006) 1.29
Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late. Br J Dermatol (2004) 1.24
Young adults and acceptance of the human papillomavirus vaccine. Public Health (2008) 1.21
Immunohistochemical differentiation between inflammatory linear verrucous epidermal nevus (ILVEN) and psoriasis. Eur J Dermatol (2004) 1.19
Autotransplantation of cryopreserved ovarian tissue in cancer survivors and the risk of reintroducing malignancy: a systematic review. Hum Reprod Update (2013) 1.13
Pregnancy after radical trachelectomy: a real option? Gynecol Oncol (2005) 1.10
Review of squamous premalignant vulvar lesions. Crit Rev Oncol Hematol (2008) 1.09
How stress gets under the skin: cortisol and stress reactivity in psoriasis. Br J Dermatol (2010) 1.05
Common burden of chronic skin diseases? Contributors to psychological distress in adults with psoriasis and atopic dermatitis. Br J Dermatol (2005) 1.02
Risk factors for short- and long-term complications after groin surgery in vulvar cancer. Br J Cancer (2011) 1.00
Individual differences in the effect of daily stressors on psoriasis: a prospective study. Br J Dermatol (2009) 0.97
Prevalence of physical symptoms of itch, pain and fatigue in patients with skin diseases in general practice. Br J Dermatol (2007) 0.96
Outcome of BRCA1- compared with BRCA2-associated ovarian cancer: a nationwide study in the Netherlands. Ann Oncol (2013) 0.95
The prevalence of onychomycosis in psoriatic patients: a systematic review. J Eur Acad Dermatol Venereol (2013) 0.93
Fatal cases of gestational trophoblastic neoplasia over four decades in the Netherlands: a retrospective cohort study. BJOG (2012) 0.92
A comparison of quality of life between vulvar cancer patients after sentinel lymph node procedure only and inguinofemoral lymphadenectomy. Gynecol Oncol (2009) 0.92
Numerous high-risk epithelial lesions in familial breast cancer. Eur J Cancer (2006) 0.92
Long-term follow-up after large-loop excision of the transformation zone: evaluation of 22 years treatment of high-grade cervical intraepithelial neoplasia. Int J Gynecol Cancer (2006) 0.91
EGFR expression is associated with groin node metastases in vulvar cancer, but does not improve their prediction. Gynecol Oncol (2006) 0.89
Young adults awareness of HPV and vaccine acceptance after introduction of the HPV vaccine in the Dutch national vaccination program. Eur J Gynaecol Oncol (2011) 0.89
Effects of HPV detection in population-based screening programmes for cervical cancer; a Dutch moment. Gynecol Oncol (2005) 0.89
Abnormal cervical cytology in women eligible for IVF. Hum Reprod (2006) 0.89
First case of vaginal radical trachelectomy in a pregnant patient. Int J Gynecol Cancer (2008) 0.89
Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome. Br J Dermatol (2008) 0.89
Prospective follow-up of 2,065 young unscreened women to study human papillomavirus incidence and clearance. Int J Cancer (2013) 0.88
Paediatric-onset psoriasis is associated with ERAP1 and IL23R loci, LCE3C_LCE3B deletion and HLA-C*06. Br J Dermatol (2012) 0.88
Identification of lesional CD4+ CD25+ Foxp3+ regulatory T cells in Psoriasis. Dermatology (2006) 0.88
Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia. Gynecol Oncol (2012) 0.87
Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12. Acta Derm Venereol (2002) 0.87
Psychosocial well-being of patients with skin diseases in general practice. J Eur Acad Dermatol Venereol (2007) 0.87
Consistency of data in six phase III clinical studies of a two-compound product containing calcipotriol and betamethasone dipropionate ointment for the treatment of psoriasis. J Eur Acad Dermatol Venereol (2006) 0.87
HPV-related (pre)malignancies of the female anogenital tract in renal transplant recipients. Crit Rev Oncol Hematol (2012) 0.87
Trends in incidence and survival of Dutch women with vulvar squamous cell carcinoma. Eur J Cancer (2013) 0.86
Quality of life and sexual health in patients with genital psoriasis. Br J Dermatol (2011) 0.86
Fluctuations in prevalence of cervical human papillomavirus in women frequently sampled during a single menstrual cycle. Br J Cancer (2002) 0.86
Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent. Aliment Pharmacol Ther (2006) 0.86
Determinants of drug survival for etanercept in a long-term daily practice cohort of patients with psoriasis. Br J Dermatol (2014) 0.86
'Happy' drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network. Br J Dermatol (2014) 0.86
The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis. Exp Dermatol (2004) 0.86
Reflectance confocal microscopy: an effective tool for monitoring ultraviolet B phototherapy in psoriasis. Br J Dermatol (2012) 0.85
The impact of a false-positive MRI on the choice for mastectomy in BRCA mutation carriers is limited. Ann Oncol (2007) 0.85
Efficacy and safety of combinations of first-line topical treatments in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol (2012) 0.85
Cellular features of psoriatic skin: imaging and quantification using in vivo reflectance confocal microscopy. Cytometry B Clin Cytom (2010) 0.84
A placebo-controlled randomized study on the clinical effectiveness, immunohistochemical changes and protoporphyrin IX accumulation in fractionated 5-aminolaevulinic acid-photodynamic therapy in patients with psoriasis. Br J Dermatol (2006) 0.84
Prediction of lymph node metastases in vulvar cancer: a review. Int J Gynecol Cancer (2006) 0.84
Balance of Treg vs. T-helper cells in the transition from symptomless to lesional psoriatic skin. Br J Dermatol (2013) 0.84
Etanercept combined with methotrexate for high-need psoriasis. Br J Dermatol (2008) 0.84
Localized distribution of human papillomavirus genotypes in the uterine cervix. Eur J Gynaecol Oncol (2002) 0.84
Increased incidence of squamous cell carcinoma of the skin after long-term treatment with azathioprine in patients with auto-immune inflammatory rheumatic diseases. J Eur Acad Dermatol Venereol (2012) 0.84
Coexisting high-grade glandular and squamous cervical lesions and human papillomavirus infections. Br J Cancer (2003) 0.84
Heterogeneity of fluorescence in psoriasis after application of 5-aminolaevulinic acid: an immunohistochemical study. Br J Dermatol (2006) 0.84
Absolute depth of myometrial invasion in endometrial cancer is superior to the currently used cut-off value of 50%. Gynecol Oncol (2013) 0.83
The differential effect of broad band vs narrow band UVB with respect to photodamage and cutaneous inflammation. Exp Dermatol (2003) 0.83
Acitretin treatment of premalignant and malignant skin disorders in renal transplant recipients: clinical effects of a randomized trial comparing two doses of acitretin. J Am Acad Dermatol (2003) 0.83
An intrapatient comparison of quality of life in psoriasis in childhood and adulthood. J Eur Acad Dermatol Venereol (2010) 0.82
Changes in keratin 6 and keratin 10 (co-)expression in lesional and symptomless skin of spreading psoriasis. Dermatology (2000) 0.82
Predictors of adalimumab drug survival in psoriasis differ by reason for discontinuation: long-term results from the Bio-CAPTURE registry. J Eur Acad Dermatol Venereol (2014) 0.82
Psoriasis treatment with etanercept and efalizumab: clinical strategies influencing treatment outcome. Br J Dermatol (2008) 0.82
Topical treatment of mild to moderate plaque psoriasis with 0.3% tacrolimus gel and 0.5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression. Br J Dermatol (2008) 0.82
The psychophysiological stress response in psoriasis and rheumatoid arthritis. Br J Dermatol (2014) 0.82
Down regulation of estrogen receptor expression is an early event in human papillomavirus infected cervical dysplasia. Eur J Gynaecol Oncol (2005) 0.82
Satisfaction of treatment with biologics is high in psoriasis: results from the Bio-CAPTURE network. Br J Dermatol (2014) 0.82
Oral retinoic acid metabolism blocking agent Rambazole for plaque psoriasis: an immunohistochemical study. Br J Dermatol (2007) 0.81
Immunofluorescent surface labelling, flow sorting and culturing of putative epidermal stem cells derived from small skin punch biopsies. J Immunol Methods (2002) 0.81
Juvenile psoriasis in European and Asian children: similarities and differences. Br J Dermatol (2011) 0.81
Safety of treatment with biologics for psoriasis in daily practice: 5-year data. J Eur Acad Dermatol Venereol (2011) 0.81
Patients with usual vulvar intraepithelial neoplasia-related vulvar cancer have an increased risk of cervical abnormalities. Br J Cancer (2009) 0.81
Combinations of classical time-honoured topicals in plaque psoriasis: a systematic review. J Eur Acad Dermatol Venereol (2012) 0.81
Assessment of epidermal subpopulations and proliferation in healthy skin, symptomless and lesional skin of spreading psoriasis. Br J Dermatol (2006) 0.80
Application of leukotriene B4 and reflectance confocal microscopy as a noninvasive in vivo model to study the dynamics of skin inflammation. Skin Res Technol (2014) 0.80
Biological behavior of CIN lesions is predictable by multiple parameter logistic regression models. Carcinogenesis (2008) 0.80
Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia. Eur J Cancer (2012) 0.80
A framework for improving the quality of care for people with psoriasis. J Eur Acad Dermatol Venereol (2012) 0.80
Role of induced negative and positive emotions in sensitivity to itch and pain in women. Br J Dermatol (2012) 0.80